Novo Nordisk drops Ozempic in India: A smooth launch

Yo, listen up! Novo Nordisk just dropped Ozempic in India, a once-weekly injectable for type 2 diabetes, priced at ₹2,200. With demand on the rise and patent battles in the mix, this launch is a game-changer for folks looking for diabetes and weight-management options. The Delhi High Court's got the competition on lock till 2026, fo' shizzle!